FRIDAY AGENDA

BREAKFAST AND REGISTRATION

Pacifica Ballroom

Welcome and Introduction

Ehtisham Mahmud, MD

Interventional Cardiovascular Medicine 2025: Highlights of the Year

Ehtisham Mahmud, MD 

Intravascular Imaging is Mandatory for Optimal PCI Outcomes: IVUS or OCT

Ryan Reeves, MD 

Approach to Coronary Calcium: Rotational Atherectomy

William Penny, MD

Approach to Coronary Calcium: Intravascular Lithotripsy

TBD

Use Hemodynamic Support for High-Risk PCI: Every Time or Selectively?

TBD

Q&A / Discussion

CASE #1: Complex PCI with Coronary Calcium

Operators: Ehtisham Mahmud, MD; Lawrence Ang, MD; Daniel Kim, MD 

CASE #2: Complex PCI with LV Dysfunction

Operators: Belal Al-Khiami, MD; Daniel J. Chu, MD; Gary Ma, MD 

BREAK / VISIT EXHIBITS

KEYNOTE LECTURE #1: Acute Myocardial Infarction and Systems of Care 

TBD

Hemodynamic Support for Cardiogenic Shock: Evolution from ISAR Shock to DanGer

Ehtisham Mahmud, MD 

Hemodynamic Support for High-Risk PCI: PROTECT Trials

TBD

Chronic Total Occlusions: Hybrid Approach

TBD

Calcified Coronary Nodules: Management Approach

TBD 

DISCUSSION / Q&A  

LUNCH / VISIT EXHIBITS  

Left Atrial Appendage Occlusion: Better Option Than  DOACs?

Jonathan C. Hsu, MD 

Percutaneous Mitral Valve Repair for Functional MR: Heart Failure Specialist Perspective

TBD

Tricuspid TEER or Replacement: Is QOL an Adequate Endpoint for Clinical Practice?

Ori Ben-Yehuda, MD 

KEYNOTE LECTURE #3: The Development of Tricuspid TEER and Tricuspid Valve Replacement from Concept to Mainstream 

TBD

Q&A / Discussion 

CASE #3: RENAL DENERVATION

Operators: Ehtisham Mahmud, MD; Belal Al-Khiami, MD; Daniel J. Chu, MD

CASE #4: TAVR: Minimalist Approach with LV Pacing

Operators: Ryan Reeves, MD; Gary Ma, MD; Daniel Kim, MD

BREAK / VISIT EXHIBITS

KEYNOTE LECTURE #4: How to Incorporate OCT in Contemporary Practice 

TBD

Assessment of Intermediate Coronary Lesions: FFR, iFR, CT-FFR or AngioFFR

Lawrence Ang, MD 

Coronary Perforations Still Happen: Toolkit and a Systematic Approach

TBD

Access Site Complications: Minimize and Manage

Rajiv Jauhar, MD 

Coronary Drug-Coated Balloon: AGENT Trial in Practice

Gary Ma, MD 

Cardiogenic Shock: SCAI Stages and Implications

TBD

Q&A / Discussion 

Concluding Remarks

Ehtisham Mahmud, MD